MAM
SPRB

Marquette Asset Management’s Spruce Biosciences SPRB Stock Holding History

Marquette Asset Management’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-743
Closed -$163K – 211
2023
Q4 		$163K Hold
743
– – 0.03% 84
2023
Q3 		$126K Hold
743
– – 0.03% 91
2023
Q2 		$120K Hold
743
– – 0.03% 101
2023
Q1 		$123K Sell
743
-168
-18% -$31.2K 0.03% 101
2022
Q4 		$75K Buy
911
+56
+7% +$4.69K 0.02% 130
2022
Q3 		$88K Hold
855
– – 0.03% 117
2022
Q2 		$112K Buy
855
+310
+57% +$39.7K 0.03% 122
2022
Q1 		$82K Hold
545
– – 0.02% 162
2021
Q4 		$182K Buy
+545
New +$162K 0.04% 107

Other funds holding SPRB

RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
SCM
Superstring Capital Management New York $158M AUM 418.32% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Marquette Asset Management's SPRB Position: Q1 2024 in Review

Marquette Asset Management sold out of Spruce Biosciences (SPRB) in Q1 2024, closing a stake of 743 shares — an estimated $163K sold.

Marquette Asset Management first reported a position in SPRB in Q4 2021 and held it in 9 quarters. The position peaked at $182K in Q4 2021. 49 funds tracked by Wall St. Rank hold SPRB as of Q1 2024.

  • Marquette Asset Management reported no remaining Spruce Biosciences position as of Q1 2024 after selling out during the quarter.
  • Marquette Asset Management sold 743 Spruce Biosciences shares in Q1 2024, an estimated $163K.
  • Marquette Asset Management first reported a position in Spruce Biosciences in Q4 2021 and held it in 9 quarters.
  • Marquette Asset Management's Spruce Biosciences position peaked at $182K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2024.

Based on Marquette Asset Management's 13F filing for Q1 2024, filed 6 May 2024.